Publicacións nas que colabora con José Luis Martínez Sande (59)

2024

  1. Impact of initiation of SGLT2 inhibitor treatment on the development of arrhythmias in patients with implantable cardiac devices

    Revista Espanola de Cardiologia

2023

  1. Atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy: a prospective multicentre study

    ESC Heart Failure, Vol. 10, Núm. 5, pp. 3055-3066

  2. Characterization of Atrial Substrate to Predict the Success of Pulmonary Vein Isolation: The Prospective, Multicenter MASH-AF II (Multipolar Atrial Substrate High Density Mapping in Atrial Fibrillation) Study

    Journal of the American Heart Association, Vol. 12, Núm. 1, pp. e027795

  3. Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation

    Cells, Vol. 12, Núm. 4

  4. Clinical and cost-effectiveness results of an on-call program for pacemaker implantations

    Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 936-937

  5. Endocardial ganglionated plexi ablation in a patient with cardioinhibitory carotid sinus syndrome

    Revista Espanola de Cardiologia, Vol. 76, Núm. 1, pp. 66-67

  6. Gender-Related Differences in Atrial Substrate in Patients with Atrial Fibrillation

    American Journal of Cardiology, Vol. 203, pp. 451-458

  7. Plasma miR-486-5p Expression Is Upregulated in Atrial Fibrillation Patients with Broader Low-Voltage Areas

    International Journal of Molecular Sciences, Vol. 24, Núm. 20

  8. Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2022

  1. Changes in autonomic response during cardioneuroablation in an elderly patient with carotid sinus syndrome

    HeartRhythm Case Reports, Vol. 8, Núm. 11, pp. 781-785

  2. Circulating miR-499a and miR-125b as Potential Predictors of Left Ventricular Ejection Fraction Improvement after Cardiac Resynchronization Therapy

    Cells, Vol. 11, Núm. 2

  3. Ethanol infusion in the vein of Marshall: A potential bail-out strategy in cardioneuromodulation procedures?

    HeartRhythm Case Reports, Vol. 8, Núm. 12, pp. 807-810

  4. Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers

    Scientific Reports, Vol. 12, Núm. 1

  5. The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

2021

  1. Leadless pacemaker implantation with hybrid image mapping technique in a congenital heart disease case

    HeartRhythm Case Reports, Vol. 7, Núm. 12, pp. 797-800

  2. Long-term cardiac reverse remodeling after cardiac resynchronization therapy

    Journal of Arrhythmia, Vol. 37, Núm. 3, pp. 653-659

  3. Long-term prognosis of women with Brugada syndrome and electrophysiological study

    Heart Rhythm, Vol. 18, Núm. 5, pp. 664-671

  4. Neuromodulatory Approaches for Atrial Fibrillation Ablation

    European Cardiology Review , Vol. 16

  5. Sex-related differences of fatty acid-binding protein 4 and leptin levels in atrial fibrillation

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 23, Núm. 5, pp. 682-690

2019

  1. A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population

    International Journal of COPD, Vol. 14, pp. 371-380